GSK shareholders approve Novartis deal

5 January 2015 - Deborah Wilkes

Archived

GlaxoSmithKline's shareholders have approved the company's proposed three-part interconditional transaction with Novartis, which will lead to the formation of a global consumer healthcare joint venture between the two companies.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: